文献速递美容整形

局部应用与局部注射氨甲环酸减少鼻整形术后水肿和瘀斑:一项三盲随机对照试验

Route Matters: Topically Applied vs Locally Injected Tranexamic Acid for the Reduction of Postrhinoplasty Edema and Ecchymosis.
PubMed 文献 · Aesthet Surg J · 2026-01-01

该三盲随机对照试验纳入75例初次开放式鼻整形患者,比较局部应用氨甲环酸(TXA)、局部注射TXA与生理盐水对照在减少围眶水肿和瘀斑方面的疗效。结果显示两种TXA途径均显著优于对照,且局部应用在术后第1天和第3天减少水肿和瘀斑的效果优于注射组,但第7天差异无统计学意义。研究强调给药途径对优化鼻整形术后美学恢复的重要性。

要点

  • 局部应用TXA在术后早期(第1、3天)减少水肿和瘀斑优于局部注射,但第7天差异无统计学意义。
  • 两种TXA给药途径均显著减少术后各时间点的水肿和瘀斑,且未观察到不良事件。
  • 给药途径影响鼻整形术后恢复效果,局部应用TXA可能更有利于早期美学恢复。

核心结论

  • 与局部注射TXA相比,截骨后立即局部应用TXA在术后早期(第1天和第3天)更大程度减少围眶水肿和瘀斑。

研究设计与样本

  • 三盲、随机、对照临床试验,纳入75例初次开放式鼻整形患者,分为局部应用TXA组(截骨后以浸透2.5 mL 100 mg/mL TXA的纱布垫应用5分钟)、局部注射TXA组(术前注射2.5 mL 100 mg/mL TXA)和生理盐水对照组,所有手术由同一外科医生使用标准化压电辅助截骨完成。

主要发现

  • 两种TXA组在所有时间点(术后第1、3、7天)的水肿和瘀斑均显著低于对照组(P < .05)。
  • 局部应用TXA组在术后第1天和第3天的水肿和瘀斑减少程度大于注射组,但第7天差异无统计学意义。
  • 未观察到不良事件。

关键数值与推荐

  • 局部应用TXA:截骨后以浸透2.5 mL 100 mg/mL TXA的纱布垫应用5分钟。
  • 局部注射TXA:术前注射2.5 mL 100 mg/mL TXA。
  • 术后第1、3、7天由盲法评估者使用经验证的照片分级量表评估水肿和瘀斑。

临床怎么用

  • 鼻整形术中截骨后局部应用TXA可考虑作为减少术后早期围眶水肿和瘀斑的给药途径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) is widely used to reduce postoperative edema and ecchymosis; however, evidence comparing topically applied and locally injected routes following rhinoplasty remains limited and inconsistent. OBJECTIVES: The aim of this study was to compare the efficacy of topically applied vs locally injected TXA in reducing periorbital edema and ecchymosis after primary rhinoplasty and to explore whether the route of administration influences clinical outcomes. METHODS: In this triple-blind, randomized, controlled clinical trial, 75 patients undergoing primary open rhinoplasty were allocated into 3 groups: topical TXA (2.5 mL of 100 mg/mL applied through a soaked pad for 5 min after osteotomy), locally injected TXA (2.5 mL of 100 mg/mL injected just before surgery), and saline control. A single surgeon performed all procedures using standardized piezo-assisted osteotomies. Postoperative edema and ecchymosis were evaluated on postoperative Days 1, 3, and 7 by a blinded assessor using validated photographic grading scales. Statistical analyses were performed using the Kruskal-Wallis and Mann-Whitney U tests with Bonferroni correction. RESULTS: Both TXA groups demonstrated significantly reduced edema and ecchymosis compared with the control at all time points (P < .05). The topical TXA group exhibited greater reductions than the injection group on Days 1 and 3, although differences were not statistically significant by Day 7. No adverse events were observed. CONCLUSIONS: Compared with locally injected TXA, topically applied TXA administered immediately after osteotomy achieved greater early reduction in postoperative periorbital edema and ecchymosis. These findings underscore the importance of the administration route in optimizing aesthetic recovery after rhinoplasty. LEVEL OF EVIDENCE: 2 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Vural O, Ozer C. Route Matters: Topically Applied vs Locally Injected Tranexamic Acid for the Reduction of Postrhinoplasty Edema and Ecchymosis. Aesthet Surg J. 2026. PMID: 41419221. doi:10.1093/asj/sjaf269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。